http://investors.somaxon.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165en-usShareholder.com RSS Feedhttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=746064Wed, 06 Mar 2013 21:55:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=746064Pernix Therapeutics Completes Acquisition of Somaxon Pharmaceuticals, Inc.http://investors.somaxon.com/releasedetail.cfm?ReleaseID=738100Tue, 05 Feb 2013 21:30:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=738100Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavishttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=727354Mon, 17 Dec 2012 21:35:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=727354Somaxon Announces That Paladin Labs Has Received Approval of New Drug Submission for Silenor (R) in Canadahttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=726049Tue, 11 Dec 2012 12:00:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=726049Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.http://investors.somaxon.com/releasedetail.cfm?ReleaseID=717600Wed, 31 Oct 2012 20:00:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=717600Somaxon Pharmaceuticals Reports Third Quarter 2012 Financial Resultshttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=715202Mon, 22 Oct 2012 20:30:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=715202Somaxon Pharmaceuticals to Report Third Quarter 2012 Results and Conduct Conference Call on Wednesday, October 31http://investors.somaxon.com/releasedetail.cfm?ReleaseID=712769Thu, 11 Oct 2012 12:05:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=712769Somaxon Pharmaceuticals Approves 1-for-8 Reverse Stock Split and Decrease in the Number of Authorized Shares of Its Common Stock to 25,000,000 Shareshttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=702598Mon, 27 Aug 2012 20:30:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=702598Somaxon Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conferencehttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=698916Tue, 07 Aug 2012 20:00:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=698916Somaxon Pharmaceuticals Reports Second Quarter 2012 Financial Resultshttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=696353Mon, 30 Jul 2012 12:00:00 GMThttp://investors.somaxon.com/releasedetail.cfm?ReleaseID=696353Somaxon Pharmaceuticals to Report Second Quarter 2012 Results and Conduct Conference Call on Tuesday, August 7